Skip to main content
v2026.11,986 entries · CC-BY 4.0

Editorial · CASRAI · Funding lifecycle and financial vocabulary

Cassidy halts Senate committee vote on Jim O’Neill’s nomination to lead NSF

HELP Chair Bill Cassidy canceled the November 18 committee vote on James O’Neill to lead NSF, citing his record at HHS and the CDC.

Published 18 Nov 2026· 5 minute read
Exterior of the National Science Foundation headquarters building in Alexandria, Virginia, during construction in 2015
Photo: Antony-22 / Wikimedia Commons, CC BY-SA 4.0 (cropped). Source · Licence

Senate Health, Education, Labor and Pensions (HELP) Committee Chair Bill Cassidy (R-La.) said on November 18, 2026, that James O’Neill, President Trump’s nominee to direct the National Science Foundation, would not get the committee vote scheduled for that day, a new development since the Union of Concerned Scientists urged senators to reject him. The nomination stays alive, but NSF remains without a Senate-confirmed director.

What happened on November 18

The HELP Committee had listed O’Neill’s nomination on the agenda of its November 18 executive session, as CASRAI reported on November 15. At the business meeting, Cassidy announced that the vote on O’Neill would not go ahead. STAT reported that Cassidy canceled the vote because O’Neill lacked the support needed to advance. FedScoop reported that Cassidy told the meeting O’Neill would not receive a vote.

Cassidy’s stated reasons concerned O’Neill’s record at the Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC). As reported by STAT and FedScoop, Cassidy said that as acting CDC director O’Neill “did not do enough to stand up for science” and against “irresponsible decisions and statements” from HHS Secretary Robert F. Kennedy Jr. Scientific American reported that Cassidy also said O’Neill’s role in the firing of former CDC director Susan Monarez “raised further concerns about the independent judgment he would bring to NSF.”

Cassidy also said, “I like Jim personally,” and that the position “requires leadership and fortitude,” according to FedScoop.

Key details

  • Date and venue: Wednesday, November 18, 2026, HELP Committee executive session.
  • Status of the nomination: The White House did not withdraw it. A White House official told FedScoop the nomination had not been withdrawn, and the Washington Examiner reported that a White House spokesperson confirmed the same.
  • Vote count: No committee vote was taken, so there is no tally. Cassidy said several committee members doubted O’Neill could lead NSF objectively, given his HHS record, according to the Washington Examiner.
  • Term: If confirmed, O’Neill would have served a six-year term, STAT reported.
  • Same meeting: The White House had withdrawn its FDA commissioner nominee, Heidi Overton, on the night of November 17, because it lacked the votes, according to FedScoop; Scientific American reported Cassidy saying she had a viable path to confirmation.

Background and context

O’Neill was nominated in March 2026 after the resignation of NSF’s previous director, Sethuraman “Panch” Panchanathan, and has not had a public confirmation hearing, as covered in CASRAI’s earlier report. Research groups, including AAAS, AAU and COSSA, and Representative Zoe Lofgren, the ranking member of the House Science Committee, had asked Cassidy for a public hearing. At least two Senate Democrats asked for the same that week, FedScoop reported.

O’Neill served as HHS deputy secretary and acting CDC director. The Washington Examiner describes his earlier career as centered on health policy and anti-aging science, including managing Mithril Capital Management for Peter Thiel and leading the SENS Research Foundation, and notes that NSF, with a budget of nearly $9 billion, funds mainly nonmedical science and engineering. CASRAI’s earlier coverage, citing AIP, reported that Brian Stone, who has performed the director’s duties for more than a year, announced his retirement plans in October.

Reaction

The statements on record come from Cassidy himself. Before the meeting, the Union of Concerned Scientists had argued that NSF should be led by someone with a scientific or engineering background, and Stand Up for Science had asked for a public hearing before any vote. Scientific American reported that the White House did not immediately comment and that an NSF spokesperson declined to comment.

What it means for researchers, universities and research offices

For institutions holding NSF awards, nothing in the proposal and award process changes today. NSF programs continue under the existing leadership arrangement, and the rules research offices follow remain those in the NSF Proposal and Award Policies and Procedures Guide (PAPPG). What changes is the outlook. A Senate-confirmed director would set strategic direction, and the absence of one prolongs a period in which priorities are set by acting officials.

Research offices tracking policy volatility should note that NSF recently dropped contested grant-policy changes; see CASRAI’s report on NSF dropping OMB-based grant policy changes. That decision was made without a Senate-confirmed director, which is the practical context for the leadership gap. Budget and award timing also depend on appropriations rather than the director; the guide to NSF budget appropriations and award timing explains that process, and the National Science Foundation entry covers the agency’s structure.

Grant-management teams can reasonably keep planning around current PAPPG terms, current notices of funding opportunity and published deadlines, and treat any leadership-driven policy shift as something that would arrive through formal NSF notices rather than a confirmation vote.

What happens next

The nomination has not been withdrawn, so it remains before the HELP Committee. The sources report no new committee date. If the committee were later to advance it, the nomination would still need Senate floor action, and the Senate’s calendar before the end of the session is limited. Nominations not confirmed by the end of the Congress are returned to the President, who can send a new nomination to the next Senate.

Sources

Ask CASRAI · free to try

Ask about this story

2 free questions a day, no account.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →